Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Remdesivir Approved by FDA Experimental Antiviral Nov/12/2020 Nov/24/2020 0
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/10/2020 Nov/24/2020 0
Convalescent plasma Emergency use authorization Used to treat other disease Other treatment Nov/05/2020 Nov/24/2020 0
Canakinumab Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/24/2020 Nov/24/2020 0
Polydatin Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020 Nov/24/2020 0
Iloprost Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/27/2020 Nov/24/2020 0
Epoprostenol Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/27/2020 Nov/24/2020 0
Icosapent ethyl Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/27/2020 Nov/24/2020 0
Cilostazol Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/27/2020 Nov/24/2020 0
Prasugrel Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/27/2020 Nov/24/2020 0